Omega-3 2100 with CoQ10 Natural Orange Flavor
Goals
$42.49 $1.41 per serving
Product analysis
Omega-3 2100 with CoQ10 Natural Orange Flavor combines omega fats with CoQ10 for heart-focused supplementation. CoQ10 may help some heart-related measures, although findings are mixed.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The omega fats are linked to an ethyl-ester preparation in the ingredient details. The CoQ10 form remains unspecified, so findings for specially prepared CoQ10 cannot be assumed to apply.
Ingredient Transparency63
All listed amounts are disclosed, but the separate EPA and DHA amounts remain unresolved. Individual form declarations are incomplete, limiting comparisons of the oil and CoQ10 preparations.
Value For Money30
The CoQ10 serving-cost comparison indicates poor value. The unresolved EPA and DHA amounts prevent a reliable active-omega cost comparison.
Customer Satisfaction73
Customer ratings are very positive, but they come from a small review base. The limited feedback leaves the picture of satisfaction less established.
Product Focus74
CoQ10 provides the clearest connection to heart-related measures in selected adults, with mixed findings. The wider claims for metabolism, longevity, skin and energy depend on populations or preparations that do not clearly match this supplement.
- Format
Softgel - Container
- 90 Softgel(s)
- Per serving
- $1.41
- Customer rating
- 4.8 · 69 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 150 mg
Coenzyme Q10 may contribute to blood-pressure, lipid and blood-vessel measures in selected adults, although results are mixed. Fish oil also supplies EPA and DHA, but their individual amounts are undisclosed, so the oil’s weight cannot establish their contribution. The supported expectation therefore rests on conventional CoQ10 and concerns intermediate measures rather than cardiovascular-event prevention.
How this product is rated for Heart Health
Ingredient fit92
The declared active ingredients are focused on the heart-related roles included here. The relevant declared amounts fully meet or nearly meet the saved exposure comparison; this does not establish an optimal regimen.
Goal fit
The declared active ingredients are focused on the heart-related roles included here.
Dose adequacy
The relevant declared amounts fully meet or nearly meet the saved exposure comparison; this does not establish an optimal regimen.
Pathways60
The strongest saved connection is to blood-vessel function. Coverage across other heart-related roles is limited.
Depth
The strongest saved connection is to blood-vessel function.
Breadth
The broader saved findings cover blood-vessel function. .
Evidence98
Coenzyme Q-10 leads the saved evidence finding. Accepted preparation matches do not remove the ingredient-specific limitations described above.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution in the saved comparison; its clinical limitations still apply.
Studied preparation
The saved finding accepts the preparations used for its included ingredients; it does not establish that every labelled preparation matches a clinical trial.
Formulation logic100
The saved checks find no missing required partner or configured conflict. The included amounts pass the minimum comparison screen.
Partner coverage
The included ingredients do not lack a required partner under the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients included in this amount screen meet its minimum comparison level; that level is not a proven effective dose.
Impact
Highest effect
Coenzyme Q-10 · 150 mg
CoQ10 provides the confirmed cardiovascular connection, with limited support for blood-pressure, lipid and blood-vessel-lining markers in people with dyslipidemia. Its 150 mg per three-softgel serving exceeds the reviewed generic CoQ10 amount anchor without establishing extra benefit or a superior delivery form. The omega-3 oil total cannot establish EPA or DHA exposure: their imported ingredient declarations remain unresolved, so triglyceride-related contributions were not counted.
How this product is rated for Cardiovascular Support
Ingredient fit92
CoQ10 is the only confirmed contributing ingredient and fully met the saved amount comparison. EPA and DHA remain unresolved despite retained label claims.
Goal fit
CoQ10 provides the confirmed focus; the omega-3 carrier total adds no independent contribution.
Dose adequacy
CoQ10 reached the configured amount endpoint. EPA and DHA amounts could not be established from the unresolved imported declarations.
Pathways60
The saved findings concentrate on blood-vessel-lining function through CoQ10. No EPA or DHA contribution was counted toward triglyceride metabolism.
Depth
Blood-vessel-lining function was the best-covered route through CoQ10.
Breadth
Only the vessel-lining route reached the coverage threshold; unresolved EPA and DHA data did not add triglyceride coverage.
Evidence88
CoQ10 supplied the strongest confirmed evidence and its generic preparation was accepted. Relevant findings concern markers in dyslipidemia rather than established event prevention.
Evidence strength
CoQ10 supplied the strongest confirmed evidence, with limited marker findings in dyslipidemia rather than general cardiovascular-event prevention.
Studied preparation
Declared CoQ10 was accepted as a studied preparation; the declaration does not establish ubiquinol or delivery-form superiority.
Formulation logic100
CoQ10 met the amount threshold with no unmet partner or configured conflict. The omega-3 total does not establish added benefit alongside it.
Partner coverage
CoQ10 had no unmet partner requirement; no extra benefit from the oil combination was established.
Conflicts
No configured caffeine, stimulant or high-sodium conflict applied.
Effective doses
CoQ10 cleared the configured minimum amount threshold; EPA and DHA remained uncounted because their active declarations were unresolved.
Impact
Highest effect
Coenzyme Q-10 · 150 mgOmega-3 · 2100 mg
Omega-3 has a preliminary signal for fewer total falls in older adults, but the primary clinical findings did not establish broadly applicable preservation of function. CoQ10 has limited visible-skin findings for an identified water-soluble preparation. This product's unspecified CoQ10 preparation cannot be assumed equivalent, so its declared amount does not establish the same wrinkle or smoothness effects.
How this product is rated for Longevity
Ingredient fit89
The formula's focus and amounts produce a relatively close fit with the saved ingredient references. The overall roles remain bounded by the specific evidence for this product.
Goal fit
The relevant ingredients are concentrated on this goal, although links to other uses affect its focus.
Dose adequacy
The recognized amounts broadly approach the saved references, with some limitations in amount or preparation.
Pathways58
The saved findings are strongest for chronic inflammation control, with limited breadth across the other aging-related processes.
Depth
The strongest saved finding concerns chronic inflammation control; this describes ingredient roles rather than a demonstrated slowing of aging.
Breadth
Only one pathway reaches the saved coverage threshold, leaving the formula's recognized reach narrow.
Evidence81
Omega-3 drives the leading saved evidence finding. The ingredient-specific limitations above still restrict which practical benefits can be expected.
Evidence strength
Omega-3 supplies the leading saved evidence finding, but its specific population and outcome limitations still apply.
Studied preparation
Coenzyme Q-10 lacks the recognized preparation match; the other qualifying ingredients supply the preparation finding.
Formulation logic100
The saved formulation findings identify no matched conflicts and no missing required partners. Amount limitations are retained in the individual findings.
Partner coverage
The recognized ingredients either work independently or have their required partner; no extra combination benefit is established.
Conflicts
No matched ingredient conflict was recorded in the supplied calculation.
Effective doses
All recognized ingredients meet the saved amount threshold, which is a calculation reference rather than proof of anti-aging efficacy.
Impact
High effect
Coenzyme Q-10 · 150 mg
Coenzyme Q10 has limited evidence for a change in TNF-alpha in statin-treated people with coronary artery disease; CRP and IL-6 did not improve in that trial. This does not establish routine clinical anti-inflammatory benefit. The fish-oil and EPA/DHA facts remain unresolved here, so no active amount can be inferred from them.
How this product is rated for Inflammation
Ingredient fit61
The relevant ingredients account for the assessed actives, with uses extending beyond inflammation. Retained quantities partly cover the comparison anchors; lower amounts do not establish proportionally smaller clinical effects.
Goal fit
The relevant ingredients account for the assessed actives, with uses extending beyond inflammation.
Dose adequacy
Retained quantities partly cover the comparison anchors; lower amounts do not establish proportionally smaller clinical effects.
Pathways19
Oxidative and mitochondrial stress is the strongest recorded area; biological coverage does not itself establish symptom improvement.
Depth
Oxidative and mitochondrial stress is the strongest recorded area; biological coverage does not itself establish symptom improvement.
Breadth
None of the evaluated mechanisms reached the coverage threshold.
Evidence93
Coenzyme Q-10 leads the eligible evidence findings, while the clinical context limits expectations of general anti-inflammatory benefit.
Evidence strength
Coenzyme Q-10 leads the eligible evidence findings, while the clinical context limits expectations of general anti-inflammatory benefit.
Studied preparation
Eligible preparations match the supplied comparison findings; this does not establish clinical benefit beyond the reviewed populations and outcomes.
Formulation logic100
No configured ingredient conflict was found. All retained ingredients meet the minimum comparison threshold; this threshold is not a proven effective dose for clinical anti-inflammatory relief.
Partner coverage
The retained ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was found.
Effective doses
All retained ingredients meet the minimum comparison threshold; this threshold is not a proven effective dose for clinical anti-inflammatory relief.
Impact
High effect
Omega-3 · 2100 mg
Omega-3 fatty acids may modestly ease joint pain and stiffness, particularly in inflammatory joint conditions; osteoarthritis results are mixed and several large trials found no benefit. The supplied serving contributes to this inflammation-related support, without establishing prevention or cartilage repair. The declared omega-3 total is retained as supplied; separate EPA and DHA entries remain unresolved and receive no additional contribution.
How this product is rated for Joint Health
Ingredient fit78
The counted declarations reach the saved amount references; this does not establish a daily regimen or guaranteed symptom relief.
Goal fit
Joint-related ingredients share the formula with actives directed toward other goals, reducing its focus on joint support.
Dose adequacy
The counted declarations reach the saved amount references; this does not establish a daily regimen or guaranteed symptom relief.
Pathways46
Omega-3 fatty acids provide the main inflammation-related joint contribution.
Depth
Omega-3 fatty acids provide the main inflammation-related joint contribution.
Breadth
Only the inflammation-related category reaches the saved breadth threshold; the other joint categories have no comparable contribution.
Evidence69
Omega-3 supplies the strongest evidence contribution, with small or inconsistent joint-symptom effects across different populations and preparations.
Evidence strength
Omega-3 supplies the strongest evidence contribution, with small or inconsistent joint-symptom effects across different populations and preparations.
Studied preparation
The saved finding accepts the omega-3 declarations, without establishing equivalence across every oil preparation or joint population.
Formulation logic100
The counted ingredients have no missing partner requirement, and no matched conflicts were identified. Their amounts meet the saved minimum criterion.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings; this does not establish added benefit from combining them.
Conflicts
No ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not a proven clinical-effect threshold.
Impact
High effect
Omega-3 · 2100 mg
Omega-3 supplies fatty acids relevant to barrier lipids, while selected wrinkle and elasticity findings exist for a particular water-soluble CoQ10 preparation. The generic Coenzyme Q-10 declaration does not establish that studied preparation or its active content; a separate CoQ10 identity remains unresolved. The saved barrier and antioxidant findings therefore do not establish routine skin benefits from this combination.
How this product is rated for Skin Health
Ingredient fit92
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product is linked to several goals.
Dose adequacy
The ingredients included in this finding meet the saved amount criteria; this does not establish extra benefit from larger amounts.
Pathways50
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Depth
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Breadth
One skin mechanism reaches the coverage threshold; support across other mechanisms remains limited.
Evidence68
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
Coenzyme Q-10 lacks a confirmed match to the specific preparation used in the skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 30 Calorie(s) | |
Total Fat | 2.5 Gram(s) | |
Cholesterol | 10 mg | |
Protein | 1 Gram(s) | |
Total Omega-3 Fatty Acids Ethyl Esters | 2100 mg | |
Coenzyme Q10 | 150 mg |
Coenzyme Q-10 · 150 mg OverallScore38
A serving provides 150 mg of CoQ10, but its molecular form is unknown. The whole-product serving costs about $1.42.
How this ingredient is rated
Active Ingredient Quality & Bioavailability12
The molecular form of CoQ10 is unknown.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not establish whether the CoQ10 is ubiquinol or ubiquinone, limiting a form-specific comparison.
Formulation & Absorption Enhancers
The saved facts do not establish a qualifying liposomal or similar delivery claim or a black pepper extract enhancer.
Dose, Safety & Label Transparency72
The serving amount is stated as 150 mg of CoQ10.
Clinical Dosage Alignment
A serving supplies 150 mg of CoQ10, with its molecular form unknown.
Label Transparency & Fillers
The CoQ10 amount is stated; the evaluation records no flagged fillers or concerning additives in the available details.
Value20
The evaluation considers whole-product serving cost alongside the CoQ10 amount and form.
Price Per Effective Serving
A serving of the whole product costs about $1.42 and supplies 150 mg of CoQ10.
Omega-3 · 2100 mg OverallScore50
Each serving supplies 2,100 mg of omega-3 in ethyl ester form. The evaluated cost is about $0.73 per gram of EPA and DHA, although separate EPA and DHA amounts are unavailable in the saved facts.
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
The omega-3 is listed in ethyl ester form. The saved facts indicate a qualifying source and an antioxidant, but do not establish measured freshness.
Molecular Form & Absorption Potential
The omega-3 is listed in ethyl ester form.
Source Purity & Oxidative Protection
The saved facts indicate a qualifying source and an antioxidant, but do not establish measured freshness.
Dose, Safety & Label Transparency15
2,100 mg total omega-3 is recorded per serving, but the available facts do not establish the EPA and DHA breakdown or concentration.
EPA & DHA Label Specificity
The saved facts list 2,100 mg total omega-3 per serving, but not separate EPA and DHA amounts.
Active Ingredient Concentration
The EPA and DHA share of the oil cannot be determined from the available amounts.
Third-Party Purity Verification
No qualifying product purity certification or testing claim is recorded in the saved facts.
Value80
The evaluated cost is about $0.73 per gram of EPA and DHA.
Price per 1000mg of EPA+DHA
The evaluated cost is about $0.73 per gram of EPA and DHA.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.